Feasibility Study of adjuvant chemotherapy of S-1/Oxaliplatin for patients with Stage III gastric cancer patients
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000023261
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Not provided
1)Active synchronous metachronous malignancy with longer than 5year interval period without below written cases Carcinoma in situ of cervical cancer and focal cancer in adenoma of colorectal cancer. 2)Contraindication of S-1 and Oxaliplatin 3)Regular use of flucytosine, phenytoin or warfarin potassium 4)Active infection with over 38 degree fever 5)History of serious drug hypersensitivity 6)Any other serious illness or medical conditions including interstitial paresis, intestinal obstruction, pneumonitis, pulmonary fibrosis, uncontrolled diabetes, renal failure, liver failure. 7)HIV positive or active hepatitis 8)Severe diarrhea (over 4 times/day or watery diarrhea) 9)Pregnancy or lactation 10)Male intension that get with child 11) Patients who are recognized as inadequate patients by doctor with responsibility in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment completion rate of up to protocol treatment 5 courses.
- Secondary Outcome Measures
Name Time Method Adverse events occurrence rate